Literature DB >> 11312358

MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.

O Planz1, S Pleschka, S Ludwig.   

Abstract

Borna disease virus (BDV) is a highly neurotropic virus that causes Borna disease, a virus-induced immune-mediated encephalomyelitis, in a variety of warm-blooded animals. Recent studies reported that BDV can be detected in patients with psychiatric disorders. BDV is noncytopathic, replicates in the nucleus of infected cells, and spreads intraaxonally in vivo. Upon infection of susceptible cultured cells, virus can be detected in foci. Little is known about the cellular components required for BDV replication. Here, we show that the cellular Raf/MEK/ERK signaling cascade is activated upon infection with BDV. In the presence of the MEK-specific inhibitor U0126, cells get infected with BDV; however, there is a block in virus spread to neighboring cells. The effect of the inhibitor on virus spread was still observed when the compound was added 2 h postinfection but not if treatment was initiated as late as 4 h after infection. Our results provide new insights into the BDV-host cell interaction and show that virus infection can be controlled with drugs interfering with a cellular signaling pathway. Since concentrations of the MEK inhibitor required to block BDV focus formation are not toxic for the host cells, our finding may be important with respect to antiviral drug development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312358      PMCID: PMC114241          DOI: 10.1128/JVI.75.10.4871-4877.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Expression and characterization of the Borna disease virus polymerase.

Authors:  M P Walker; I Jordan; T Briese; N Fischer; W I Lipkin
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Characterization of the P protein-binding domain on the 10-kilodalton protein of Borna disease virus.

Authors:  T H Malik; M Kishi; P K Lai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with Borna disease virus infection.

Authors:  R Ferszt; K P Kühl; L Bode; E W Severus; B Winzer; A Berghöfer; G Beelitz; B Brodhun; B Müller-Oerlinghausen; H Ludwig
Journal:  Pharmacopsychiatry       Date:  1999-07       Impact factor: 5.788

4.  Increase of virus yields and releases of Borna disease virus from persistently infected cells.

Authors:  G Pauli; H Ludwig
Journal:  Virus Res       Date:  1985-02       Impact factor: 3.303

5.  Transcriptional control of Borna disease virus (BDV) in persistently BDV-infected cells.

Authors:  T Mizutani; H Inagaki; D Hayasaka; S Shuto; N Minakawa; A Matsuda; H Kariwa; I Takashima
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

6.  Activation of ERK2 by respiratory syncytial virus in A549 cells is linked to the production of interleukin 8.

Authors:  W Chen; M M Monick; A B Carter; G W Hunninghake
Journal:  Exp Lung Res       Date:  2000 Jan-Feb       Impact factor: 2.459

7.  Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells.

Authors:  A Hans; S Syan; C Crosio; P Sassone-Corsi; M Brahic; D Gonzalez-Dunia
Journal:  J Biol Chem       Date:  2000-11-09       Impact factor: 5.157

8.  Pathogenesis of Borna disease in rats: immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities.

Authors:  O Narayan; S Herzog; K Frese; H Scheefers; R Rott
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

9.  Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders.

Authors:  R Rott; S Herzog; B Fleischer; A Winokur; J Amsterdam; W Dyson; H Koprowski
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

10.  Demonstration of specific antibodies in the central nervous system of horses naturally infected with Borna disease virus.

Authors:  H Ludwig; P Thein
Journal:  Med Microbiol Immunol       Date:  1977-12-27       Impact factor: 3.402

View more
  37 in total

1.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line.

Authors:  Madiha S Ibrahim; Makiko Watanabe; J Alejandro Palacios; Wataru Kamitani; Satoshi Komoto; Takeshi Kobayashi; Keizo Tomonaga; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Localization of ERK/MAP kinase is regulated by the alphaherpesvirus tegument protein Us2.

Authors:  Mathew G Lyman; Jessica A Randall; Christine M Calton; Bruce W Banfield
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  Honglin Luo; Bobby Yanagawa; Jingchun Zhang; Zongshu Luo; Mary Zhang; Mitra Esfandiarei; Christopher Carthy; Janet E Wilson; Decheng Yang; Bruce M McManus
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway.

Authors:  Qi Zhang; Rui Gong; Jing Qu; Yijing Zhou; Weiyong Liu; Mingzhou Chen; Yingle Liu; Ying Zhu; Jianguo Wu
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

Review 6.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

7.  Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway.

Authors:  Damien Vitour; Grégory Caignard; Cindy Kundlacz; Marie Pourcelot; Aurore Fablet; Rayane Amaral Da Silva Moraes; Thibaut Léger; Bastien Morlet; Cyril Viarouge; Corinne Sailleau; Mathilde Turpaud; Axel Gorlier; Emmanuel Breard; Sylvie Lecollinet; Piet A van Rijn; Stephan Zientara
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

8.  Borna disease virus nucleoprotein interacts with the CDC2-cyclin B1 complex.

Authors:  Oliver Planz; Stephan Pleschka; Katja Oesterle; Friederike Berberich-Siebelt; Christina Ehrhardt; Lothar Stitz; Stephan Ludwig
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Suppression of coronavirus replication by inhibition of the MEK signaling pathway.

Authors:  Yingyun Cai; Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.

Authors:  Sherri L Christian; Thaddeus W Collier; Dong Zu; Maria Licursi; Chris M Hough; Kensuke Hirasawa
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.